5-Amino-1MQ Explained: NNMT, NAD⁺, and Fat Cell Metabolism 5-Amino-1MQ is showing up more and more in peptide and fat-loss conversations. But here’s the first correction: It is not actually a peptide. 5-Amino-1MQ is a small-molecule compound being studied because it inhibits NNMT — an enzyme connected to nicotinamide metabolism, NAD⁺ biology, methylation, fat-cell function, insulin sensitivity, and liver metabolism. That mechanism is why people are interested in it for metabolic health and body composition. But the evidence is still early. Most of the data comes from cell studies and animal models, including research looking at adipocytes, diet-induced obese mice, glucose tolerance, insulin sensitivity, fat mass, and fatty liver markers. Interesting? Yes. Clinically proven for human fat loss? Not yet. In this episode of Peptides Explained, we break down what 5-Amino-1MQ is, how it is proposed to work, why people are using it, what the research shows, and how to think about grey-market use responsibly. The key takeaway: 5-Amino-1MQ is interesting, but early. The mechanism deserves attention. The marketing deserves careful interpretation. And the human data still needs to catch up. This podcast is for informational purposes only and is not medical advice.